Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00194298 · ClinicalTrials.gov registry record
FDG-PET Imaging in Complicated Diabetic Foot
A clinical trial of Diabetic Foot Disease, sponsored by University of Pennsylvania.
- Active
- Registry status
- 240
- Enrollment target
- 1
- Study location
NCT00194298 is a study of Diabetic Foot Disease that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 240 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00194298, a study of Diabetic Foot Disease, is active but no longer recruiting, sponsored by University of Pennsylvania.
- ACTIVE NOT RECRUITING
- Registry status
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
The main objective of the proposed research study is to determine the potential utilization of \[18-F\] Fluorodeoxyglucose (FDG) positron emission tomography (PET) in patients with complicated diabetic foot, especially in the diagnosis or exclusion of osteomyelitis in this setting. We intend to validate and establish the necessary criteria for making such a diagnosis and determine the accuracy of the technique through comparison with other existing modalities, including MRI, and patient outcome. We expect that at the completion of the proposed research, the role of these powerful imaging modalities will be clearly defined in the management of patients with this challenging and serious complication.
Conditions Studied
Interventions
- PROCEDURE FDG-PET Imaging
Study Locations (1)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2002-10 |
| Est. Completion | 2027-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00194298
The ClinicalTrials.gov registry entry for NCT00194298 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetic Foot Disease appearing as the primary indexed condition, and to 1 intervention - of which FDG-PET Imaging is the first listed.
NCT00194298 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00194298 about?
NCT00194298 is a clinical study titled "FDG-PET Imaging in Complicated Diabetic Foot". The main objective of the proposed research study is to determine the potential utilization of \[18-F\] Fluorodeoxyglucose (FDG) positron emission tomography (PET) in patients with complicated diabetic foot, especially in the diagnosis or exclusion of osteomyelitis in this setting. We intend to vali...
What is the current status of trial NCT00194298?
This trial is currently active not recruiting. The enrollment target is 240 participants. The study started on 2002-10. Estimated completion is 2027-02.
What conditions does trial NCT00194298 study?
This clinical trial studies the following conditions: Diabetic Foot Disease.
What interventions are being tested in trial NCT00194298?
The interventions under investigation include: FDG-PET Imaging (PROCEDURE).
Who is sponsoring clinical trial NCT00194298?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00194298 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.